Drug intelligence / Profile preview

Stomatovis

Development stage
Unknown
Lead developer
DMG Italia
Administration
Topical
01

Overview

**Stomatovis** is a D.M.G. Italia oral mucosal-protection medical device supplied as a mouthwash/gargle. It is intended to prevent and treat symptoms associated with stomatitis and gingivitis of different origins and to lubricate and hydrate the oral mucosa. Its formulation includes mucosal-protective and film-forming components such as marshmallow mucilage, dipotassium glycyrrhizinate, carboxymethyl beta-glucan, phosphoglucan, PVM/MA copolymer, xylitol, glycerol, and sodium bicarbonate. It does not have a single defined pharmacologic active ingredient or molecular target; its intended effect is primarily local physical mucosal protection, lubrication, and hydration. In a randomized controlled study in adults undergoing elective genitourinary surgery with orotracheal intubation, Stomatovis gargle showed a modest but non-statistically-significant reduction in postoperative sore throat relative to control.

Brand names
Stomatovis
Other names
Stomatovis CollutorioStomatovis gargleStomatovis mouthwash
02

Targets

MUC (Mucin family)

Beyond the preview

Go deeper on Stomatovis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stomatovis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call